{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:11Z","timestamp":1761513191772,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.transproceed.2012.05.079","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T18:21:38Z","timestamp":1348597298000},"page":"574-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rosiglitazone Treatment Does Not Decrease Amyloid Deposition in Transplanted Islets From Transgenic Mice Expressing Human Islet Amyloid Polypeptide"],"prefix":"10.1016","volume":"45","author":[{"given":"J.","family":"Udayasankar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Zraika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Aston-Mourney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.M.","family":"Brooks-Worrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"Taborsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.L.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2012.05.079_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM200007273430409","article-title":"Successful islet transplantation for patients with diabetes\u2014fact or fantasy?","volume":"343","author":"Robertson","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.05.079_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.05.079_bib3","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.transproceed.2012.05.079_bib4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.05.079_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2337\/dc06-1233","article-title":"Prediction of clinical outcome in islet allotransplantation","volume":"30","author":"Bertuzzi","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.transproceed.2012.05.079_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00400722","article-title":"Rapid deposition of amyloid in human islets transplanted into nude mice","volume":"38","author":"Westermark","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.transproceed.2012.05.079_bib7","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1073\/pnas.0909024107","article-title":"Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts","volume":"107","author":"Potter","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transproceed.2012.05.079_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMc0802893","article-title":"Widespread amyloid deposition in transplanted human pancreatic islets","volume":"359","author":"Westermark","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.05.079_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/TP.0b013e31823e46ef","article-title":"Further evidence for amyloid deposition in clinical pancreatic islet grafts","volume":"93","author":"Westermark","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2012.05.079_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","article-title":"The relation of diabetes mellitus to lesions of the pancreas","volume":"5","author":"Opie","year":"1901","journal-title":"J Exp Med"},{"key":"10.1016\/j.transproceed.2012.05.079_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/03009734000000014","article-title":"Quantitative studies on amyloid in the islets of Langerhans","volume":"77","author":"Westermark","year":"1972","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.transproceed.2012.05.079_bib12","first-page":"151","article-title":"Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes","volume":"9","author":"Clark","year":"1988","journal-title":"Diabetes Res"},{"key":"10.1016\/j.transproceed.2012.05.079_bib13","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","article-title":"Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide","volume":"93","author":"Janson","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transproceed.2012.05.079_bib14","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2337\/diab.43.12.1457","article-title":"Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse","volume":"43","author":"D'Alessio","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.transproceed.2012.05.079_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0014-5793(93)81444-5","article-title":"Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM)","volume":"323","author":"Fox","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.transproceed.2012.05.079_bib16","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/BF00400803","article-title":"Chronic overproduction of islet amyloid polypeptide\/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia","volume":"36","author":"Hoppener","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.transproceed.2012.05.079_bib17","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transproceed.2012.05.079_bib18","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"Verchere","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transproceed.2012.05.079_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diabetes.52.2.372","article-title":"Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid","volume":"52","author":"Hull","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.transproceed.2012.05.079_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00125-008-1185-7","article-title":"Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets","volume":"52","author":"Udayasankar","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.transproceed.2012.05.079_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00125-008-1255-x","article-title":"Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis","volume":"52","author":"Zraika","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.transproceed.2012.05.079_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00125-011-2338-7","article-title":"cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets","volume":"55","author":"Subramanian","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.transproceed.2012.05.079_bib23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.transproceed.2012.05.079_bib24","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.4049\/jimmunol.1002854","article-title":"IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction","volume":"187","author":"Westwell-Roper","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2012.05.079_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.05.079_bib26","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.05.079_bib27","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2337\/diabetes.54.7.2235","article-title":"Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide","volume":"54","author":"Hull","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.transproceed.2012.05.079_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1463-1326.2000.00099.x","article-title":"Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat","volume":"2","author":"Smith","year":"2000","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.transproceed.2012.05.079_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2337\/diabetes.50.5.1021","article-title":"Beta-cell mass dynamics in Zucker diabetic fatty rats","volume":"50","author":"Finegood","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.transproceed.2012.05.079_bib30","doi-asserted-by":"crossref","first-page":"E560","DOI":"10.1152\/ajpendo.00561.2002","article-title":"Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion","volume":"286","author":"Lupi","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2012.05.079_bib31","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00018-008-8100-8","article-title":"Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities","volume":"65","author":"Abaraviciene","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.transproceed.2012.05.079_bib32","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1210\/jc.2005-0079","article-title":"Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3\u2032-kinase-dependent pathway","volume":"90","author":"Lin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2012.05.079_bib33","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.2003-032103","article-title":"Evidence for a potent antiinflammatory effect of rosiglitazone","volume":"89","author":"Mohanty","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2012.05.079_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2337\/db06-0430","article-title":"Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis","volume":"56","author":"Zraika","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.transproceed.2012.05.079_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-4347(00)00519-3","article-title":"Automated high-performance liquid chromatography method for the determination of rosiglitazone in human plasma","volume":"752","author":"Muxlow","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.transproceed.2012.05.079_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.transproceed.2004.11.018","article-title":"Enhancing islet engraftment with rosiglitazone","volume":"37","author":"Hsu","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2012.05.079_bib37","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0022-2275(20)33479-9","article-title":"Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice","volume":"40","author":"Edvardsson","year":"1999","journal-title":"J Lipid Res"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134512006793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134512006793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:28:18Z","timestamp":1758576498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134512006793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0041134512006793"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2012.05.079","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosiglitazone Treatment Does Not Decrease Amyloid Deposition in Transplanted Islets From Transgenic Mice Expressing Human Islet Amyloid Polypeptide","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2012.05.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}